Target Cancer | Fighting Cancer Smarter: The Power of Data @TargetCancer | Uploaded April 2024 | Updated October 2024, 2 hours ago.
Fighting Cancer Smarter: The Power of Data | TARGET: Cancer Podcast | Ep. 61
Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
- - - -TimeStamps - - - -
00:00 Introduction
07:38 The birth of Shepherd
14:00 Shephard's approach to precision and tailored therapies
17:10 The potential for cures in cancer treatment
23:47 Genomic data to improve future treatments
- - - -
#cancertreatment #cancercure #medicine #precisiononcology
đź”´Like, Subscribe, and Share to see more of this type of content!
— ABOUT DAVID HYSONG —
David is the Founder and CEO at SHEPHERD. He is an ardent champion of patient rights and a defiantly human approach to healthcare. He founded SHEPHERD with vision and a mandate- to build something that would give freedom, power, and a defiant hope back to patients when they had had none, and give them options when they had nowhere left to turn. David was diagnosed at 27 with a rare form of head and neck cancer, Adenoid Cystic Carcinoma, while a graduate student at Harvard University. He had recently completed officer selection for special operations in the U.S. military and had previously worked in Southeast Asia against human trafficking and the sexual enslavement of children. He leveraged the same commitment to working for systemic change and to help those who suffer to build SHEPHERD alongside are markable team of people equally passionate about saving patients lives. David is a Forbes 30 Under 30 honoree, Aspen Institute Spotlight Health Scholar, and Charles River Research Models in Drug Discovery Award Recipient. He is a graduate of Harvard University, St. John’s College, and Transylvania University and is also the founder of The Billion Life Project, which seeks to create market-driven solutions to humanity’s greatest suffering; and Rage to LIVE, which seeks to inspire others to overcome their own limitations to do the impossible - on behalf of others.
— ABOUT KATHERINE ARLINE —
Katherine Arline leads the development of SHEPHERD’s products. She is a graduate of Harvard University, where she studied economics, quantitative analysis, molecular and cellular biology, and bioinformatics. Prior to her work at SHEPHERD, Katherine spent fifteen years working in technology. She was running a big data startup in the Harvard Innovation Lab when a close family member was diagnosed with a rare brain cancer. Katherine and David met one month later and she asked to join the company to leverage her background in technology, data, and entrepreneurship to benefit high-need cancer patients.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com
Facebook: facebook.com/xcures.platform
TikTok: tiktok.com/@xcures.platform
Instagram: instagram.com/xcures.platform
LinkedIn: linkedin.com/company/xcures
Twitter: twitter.com/xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podcast
YouTube: youtube.com/TargetCancer
Spotify: open.spotify.com/show/2xMG5y5gOoIut5Ykvm63XO?si=0b478259417f40f4
iTunes: podcasts.apple.com/us/podcast/target-cancer-podcast/id1593087681
TuneIn:
tunein.com/podcasts/Technology-Podcasts/Target-Cancer-Podcast-p1761270/?topicId=176003304
Google Podcasts:
podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL210cnVkbmFrL2ZlZWQueG1s
Pandora:
pandora.com/podcast/target-cancer-podcast/PC:1001022571
Amazon Music:
music.amazon.com/podcasts/a8011808-57b8-42b3-a6df-abe02bb9011d
Fighting Cancer Smarter: The Power of Data | TARGET: Cancer Podcast | Ep. 61
Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
- - - -TimeStamps - - - -
00:00 Introduction
07:38 The birth of Shepherd
14:00 Shephard's approach to precision and tailored therapies
17:10 The potential for cures in cancer treatment
23:47 Genomic data to improve future treatments
- - - -
#cancertreatment #cancercure #medicine #precisiononcology
đź”´Like, Subscribe, and Share to see more of this type of content!
— ABOUT DAVID HYSONG —
David is the Founder and CEO at SHEPHERD. He is an ardent champion of patient rights and a defiantly human approach to healthcare. He founded SHEPHERD with vision and a mandate- to build something that would give freedom, power, and a defiant hope back to patients when they had had none, and give them options when they had nowhere left to turn. David was diagnosed at 27 with a rare form of head and neck cancer, Adenoid Cystic Carcinoma, while a graduate student at Harvard University. He had recently completed officer selection for special operations in the U.S. military and had previously worked in Southeast Asia against human trafficking and the sexual enslavement of children. He leveraged the same commitment to working for systemic change and to help those who suffer to build SHEPHERD alongside are markable team of people equally passionate about saving patients lives. David is a Forbes 30 Under 30 honoree, Aspen Institute Spotlight Health Scholar, and Charles River Research Models in Drug Discovery Award Recipient. He is a graduate of Harvard University, St. John’s College, and Transylvania University and is also the founder of The Billion Life Project, which seeks to create market-driven solutions to humanity’s greatest suffering; and Rage to LIVE, which seeks to inspire others to overcome their own limitations to do the impossible - on behalf of others.
— ABOUT KATHERINE ARLINE —
Katherine Arline leads the development of SHEPHERD’s products. She is a graduate of Harvard University, where she studied economics, quantitative analysis, molecular and cellular biology, and bioinformatics. Prior to her work at SHEPHERD, Katherine spent fifteen years working in technology. She was running a big data startup in the Harvard Innovation Lab when a close family member was diagnosed with a rare brain cancer. Katherine and David met one month later and she asked to join the company to leverage her background in technology, data, and entrepreneurship to benefit high-need cancer patients.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com
Facebook: facebook.com/xcures.platform
TikTok: tiktok.com/@xcures.platform
Instagram: instagram.com/xcures.platform
LinkedIn: linkedin.com/company/xcures
Twitter: twitter.com/xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podcast
YouTube: youtube.com/TargetCancer
Spotify: open.spotify.com/show/2xMG5y5gOoIut5Ykvm63XO?si=0b478259417f40f4
iTunes: podcasts.apple.com/us/podcast/target-cancer-podcast/id1593087681
TuneIn:
tunein.com/podcasts/Technology-Podcasts/Target-Cancer-Podcast-p1761270/?topicId=176003304
Google Podcasts:
podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL210cnVkbmFrL2ZlZWQueG1s
Pandora:
pandora.com/podcast/target-cancer-podcast/PC:1001022571
Amazon Music:
music.amazon.com/podcasts/a8011808-57b8-42b3-a6df-abe02bb9011d
